|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
103.26(B) |
Last
Volume: |
6,021,087 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
96,581 |
377,614 |
901,711 |
1,862,313 |
Total Sell Value |
$6,534,949 |
$22,111,166 |
$49,794,655 |
$91,194,728 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
10 |
20 |
37 |
70 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-18 |
4 |
D |
$65.82 |
$69,243 |
D/D |
(1,052) |
34,087 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,372 |
35,139 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2024-02-18 |
4 |
D |
$65.82 |
$16,982 |
D/D |
(258) |
37,982 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
638 |
38,240 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-02-18 |
4 |
D |
$65.82 |
$108,208 |
D/D |
(1,644) |
271,542 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
273,186 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-18 |
4 |
D |
$65.82 |
$120,385 |
D/D |
(1,829) |
192,867 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
194,696 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2024-02-18 |
4 |
D |
$65.82 |
$54,104 |
D/D |
(822) |
62,278 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,853 |
63,100 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2024-02-18 |
4 |
D |
$65.82 |
$476,076 |
D/D |
(7,233) |
1,673,878 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,307 |
1,681,111 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-02-17 |
4 |
D |
$65.82 |
$95,307 |
D/D |
(1,448) |
29,202 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
30,650 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-02-17 |
4 |
D |
$65.82 |
$19,351 |
D/D |
(294) |
31,803 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
32,097 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-02-17 |
4 |
D |
$65.82 |
$45,087 |
D/D |
(685) |
49,993 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
50,678 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-02-17 |
4 |
D |
$65.82 |
$100,046 |
D/D |
(1,520) |
76,032 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
77,552 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-17 |
4 |
D |
$65.82 |
$82,736 |
D/D |
(1,257) |
32,767 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,833 |
34,024 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2024-02-17 |
4 |
D |
$65.82 |
$26,591 |
D/D |
(404) |
37,602 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
38,006 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2024-02-17 |
4 |
D |
$65.82 |
$133,812 |
D/D |
(2,033) |
269,480 |
|
- |
|
2518 Records found
|
|
Page 2 of 101 |
|
|